Patent · US Active

Silybin injection and preparation method therefor

US10314923B2 · kind B2 · utility

2Cited by

0References

19Claims

0Family size

Assignee

TASLY PHARMACEUTICAL GROUP CO., LTD. · CN

Inventors

Jianming Chen · Tianjin, CN
Baoan Gao · Tianjin, CN
Qinqin ZHOU · Longbeilingcun, CN
Shuiping Zhou · Tianjin, CN
Nan Cai · Sichuan, CN
Yuansheng Zhang · Tianjin, CN
Chan Wu · Tianjin, CN
Nong YU · Tianjin, CN
Lina CHEN · Nanhu, CN
Wenli Liu · Shanghai, CN

Key dates

Filing date	Dec 24, 2015
Grant date	Jun 11, 2019
Priority date	—
Expiry date	Dec 24, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P39/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A silybin injection contains silybin, sulfobutyl ether-β-cyclodextrin, an organic solvent for injection, a pH regulator, and may further contain a co-solvent, a lyophilization bulking agent, and water for injection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.